Motor physical therapy affects muscle collagen type I and decreases gait speed in dystrophin-deficient dogs.
Golden Retriever Muscular Dystrophy (GRMD) is a dystrophin-deficient canine model genetically homologous to Duchenne Muscular Dystrophy (DMD) in humans. Muscular fibrosis secondary to cycles of degeneration/regeneration of dystrophic muscle tissue and muscular weakness leads to biomechanical adaptat...
Main Authors: | Thaís P Gaiad, Karla P C Araujo, Júlio C Serrão, Maria A Miglino, Carlos Eduardo Ambrósio |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3979701?pdf=render |
Similar Items
-
Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.
by: Karla P C Araujo, et al.
Published: (2013-01-01) -
Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs
by: Voit Thomas, et al.
Published: (2011-04-01) -
Widespread severe myodegeneration in a compound heterozygote female dog with dystrophin deficiency
by: Jessica S. Fortin, et al.
Published: (2021-05-01) -
Juvenile cardiomyopathy with dystrophin deficiency
by: Yuhui Luo, et al.
Published: (2024-05-01) -
Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy
by: Mary Chesshyre, et al.
Published: (2022-04-01)